pocketful logo
Astec Lifesciences Ltd logo

Astec Lifesciences Ltd

NSE: ASTEC BSE: 533138

623.70

(-0.66%)

Wed, 04 Mar 2026, 00:13 am

Astec Lifesciences Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    1400.77

  • Net Profit

    -134.71

  • P/B

    5.64

  • Sector P/E

    27.53

  • P/E

    -9.82

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.62

  • Interest Cover (Industry)

    2.89

  • ROCE (Industry)

    5.92

  • RONW (Industry)

    4.09

  • ROE

    -44.60

  • ROCE

    -12.60

  • Debt/Equity

    1.74

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    185.77

  • Interest Cover

    -2.84

Analysis

all

thumbs up icon

Pros

  • Astec LifeSciences's earnings growth is expected to exceed the low risk savings rate of 7.2%.
  • Astec LifeSciences's earnings are expected to exceed the low risk growth rate next year.
  • Performance (ROE) is expected to be above the current IN Chemicals industry average.
  • Astec LifeSciences's revenue growth is expected to exceed the India market average.
  • Astec LifeSciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
thumbs up icon

Cons

  • Astec LifeSciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
  • No need to calculate the sustainability of Astec LifeSciences's dividends as it is not paying a notable one for India.
  • Astec LifeSciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
  • Astec LifeSciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Astec LifeSciences's dividend is below the markets top 25% of dividend payers in India (3.08%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters71.9772.4270.8770.8766.75
FII0.040.000.020.251.20
DII3.174.014.264.345.41
Public24.8223.5724.8424.5426.64
Government00000

Read More

Technical Analysis

RSI

49.19

MACD

-2.90

50 DMA

644.02

200 DMA

756.79

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic875.90747.90685.80619.90557.80491.90363.90
Fibonacci747.90699.00668.80619.90571.00540.80491.90
Camarilla658.90647.17635.43619.90611.97600.23588.50

Pivots Level: Classic

R3

+256

875.90

R2

+128

747.90

R1

+65.90

685.80

619.90
619.90
Pivot Point
LTP: 628.25

S1

-62.10

557.80

S2

-128

491.90

S3

-256

363.90

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    627.01

  • 20-EMA

    627.55

  • 30-EMA

    632.16

  • 50-EMA

    647.38

  • 100-EMA

    684.99

  • 200-EMA

    745.01

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 Jan 2026board-meetingsQuarterly Results, Nine Months Results
29 Oct 2025board-meetingsQuarterly Results
30 Jun 2025rights1:7 Rights Issue of Equity Shares04 Jul 2025
04 Jun 2025rightsRight Issue of Equity Shares04 Jul 2025
23 Apr 2025agm
23 Jun 2024agmAnnual General Meeting24 Jul 2024
02 May 2024agm
21 Jun 2023dividendAnnual General Meeting/Dividend - Rs 1.50 Per Share22 Jul 2023
02 May 2023agm
02 May 2023dividend₹1.50 Dividend /Share22 Jul 2023

Read More

Peer Comparison

Astec Lifesciences Ltd logo

Astec Lifesciences Ltd

P I Industries Ltd logo

P I Industries Ltd

Sharda Cropchem Ltd logo

Sharda Cropchem Ltd

Dhanuka Agritech Ltd logo

Dhanuka Agritech Ltd

UPL Ltd logo

UPL Ltd

Sumitomo Chemical India Ltd logo

Sumitomo Chemical India Ltd

Read More

Astec Lifesciences Ltd About

Astec Lifesciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.

Industry

Pesticides / Agrochemicals - Indian

Founded

1994

Headquarters

CEO

N B Godrej

Employees

Contact

Website icon

Website

http://www.godrejastec.com

Email icon

Email

ipo@godrejastec.com; astecinfo@godrejastec.com; as

Phone icon

Phone

91-22-25188010

Location icon

Location

GodrejOne 3rd Fl Pirojshanagar, Vikhroli (E) Eastern Exp Highw, Mumbai, Maharashtra, 400079

Read More

Astec Lifesciences Ltd Company History

YearHistory
2018
  • Astec Lifesciences Ltd Wins Indian Chemical Council (ICC) Award For Excellence In Management
  • Astec Lifesciences Ltd amalgamated with Godrej Agrovet Limited
2019
  • Astec Lifesciences Ltd was awarded ICC Award for Excellence in Human Resource Management
2020
  • Astec Lifesciences Ltd is stake entire equity in Astec Europe Sprl
2021
  • Astec LifeSciences Limited commenced commercial production at its new Herbicide plant at Mahad
2023
  • Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development.
  • Astec LifeSciences launches R&D Center to develop new crop protection formulations.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDBuy155505737.5609 Dec 2025
HRTI PRIVATE LIMITEDSell146811735.0809 Dec 2025
MATHISYS ADVISORS LLPBuy122049733.809 Dec 2025
MATHISYS ADVISORS LLPSell119613732.4209 Dec 2025
JUNOMONETA FINSOL PRIVATE LIMITEDSell473088851.5803 Dec 2025
MUSIGMA SECURITIESBuy184208852.1303 Dec 2025
JUNOMONETA FINSOL PRIVATE LIMITEDBuy473088850.9103 Dec 2025
HRTI PRIVATE LIMITEDSell305720851.3603 Dec 2025
MUSIGMA SECURITIESSell184208852.4203 Dec 2025
HRTI PRIVATE LIMITEDBuy310871849.6503 Dec 2025

Read More

Astec Lifesciences Ltd News

Astec LifeSciences Allots 577 Shares Under ESOP

Astec LifeSciences allotted 577 equity shares upon exercise of stock options under ESOP 2012, raising Rs. 12,970 and increasing paid-up capital to Rs. 22,28,22,380.

24 Feb 2026

co actions results

Astec Lifesciences Q3 Loss Narrows to ₹157M

Astec Lifesciences reported reduced consolidated net loss of ₹157M in Q3 compared to ₹404M loss in previous year, while revenue grew 33% to ₹1.25B from ₹939M year-on-year.

30 Jan 2026

co actions results

ASTEC Lifesciences CFO Mugdha Amol Khare Resigns

ASTEC Lifesciences announces the resignation of Chief Financial Officer Mugdha Amol Khare from her position at the agrochemical company.

30 Jan 2026

stocks

Astec Lifesciences Appoints Milind Bhangaonkar as GM

Astec Lifesciences Limited has appointed Mr. Milind Bhangaonkar as General Manager-Operations (Site Head) and Senior Management Personnel effective December 15, 2025.

15 Dec 2025

stocks

Astec Lifesciences Reports Reduced Net Loss Despite Revenue Decline in Q2

Astec Lifesciences reported a consolidated net loss of 244.2 million rupees in Q2, an improvement from the previous year's loss of 385.5 million rupees. However, the company's revenue declined to 737.2 million rupees compared to 985.4 million rupees in the same quarter last year.

29 Oct 2025

earnings

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800